In conclusion, mir-204-5p is declined in osteosarcoma, and its upregulation can effectively inhibit growth activity of cell and induce apoptosis, and mir-204-5p may act on osteosarcoma cells by directly targeting DNM2. Here, DNM2 is linked to osteosarcoma.